Lupaneta Pack Interactions
There are 456 drugs known to interact with Lupaneta Pack (leuprolide/norethindrone), along with 17 disease interactions, and 5 alcohol/food interactions. Of the total drug interactions, 110 are major, 333 are moderate, and 13 are minor.
- View all 456 medications that may interact with Lupaneta Pack
- View Lupaneta Pack alcohol/food interactions (5)
- View Lupaneta Pack disease interactions (17)
Most frequently checked interactions
View interaction reports for Lupaneta Pack (leuprolide / norethindrone) and the medicines listed below.
- Abilify (aripiprazole)
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- alprazolam
- amitriptyline
- amphetamine
- aspirin
- Belsomra (suvorexant)
- Bevespi Aerosphere (formoterol / glycopyrrolate)
- Celebrex (celecoxib)
- Corlanor (ivabradine)
- Cymbalta (duloxetine)
- cyproheptadine
- Depakote (divalproex sodium)
- Deplin (l-methylfolate)
- Depo Provera (medroxyprogesterone)
- diazepam
- DOK (docusate)
- doxycycline
- Fanapt (iloperidone)
- gabapentin
- hydrocodone
- leuprolide
- lisinopril
- Lunesta (eszopiclone)
- magnesium citrate
- magnesium sulfate
- metoprolol
Lupaneta Pack alcohol/food interactions
There are 5 alcohol/food interactions with Lupaneta Pack (leuprolide / norethindrone).
Lupaneta Pack disease interactions
There are 17 disease interactions with Lupaneta Pack (leuprolide / norethindrone) which include:
- abnormal genital bleeding
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- cardiovascular disease
- diabetes
- QT interval prolongation
- bone mineral density
- seizures
- hyperlipidemia
- weight gain
More about Lupaneta Pack (leuprolide / norethindrone)
- Lupaneta Pack consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: sex hormone combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.